Alexander KarpAlexander Karp earned $1B in 2024

In 2011, John W. Rowe earned $10.25M in total compensation at Exelon, including $1.51M salary, $2.50M bonus and $4.74M in stock. Most recently acquired 1,410 shares in May 2019. Currently holds stock worth $17.84M. Led Exelon as CEO for 10 years.

Compensation History

Annual executive compensation data for John W. Rowe, including salary, bonuses, and stock awards.

Year

2011

Total Compensation

$10.25M

Salary

$1.51M

Bonus

$2.50M

Other

$1.51M

Salary

$1.51M

Board Justification

Exelon's compensation philosophy emphasizes performance-based pay, aligning executive compensation with company performance and shareholder interests.

Bonus

$2.50M

Board Justification

Annual incentive payment based on performance metrics achieved, specifically adjusted (non-GAAP) operating earnings per share, which were $4.16, or 131.43% of target.

Other Compensation

$1.51M

Board Justification

Includes various forms of compensation such as retirement benefits and other perquisites, excluding stock or options.

Restricted Stock

$4.74M118.91K Performance Share Units

Board Justification

Performance share units awarded based on achieving performance goals, valued at the stock price on the award date.

Performance Metrics

Adjusted (non-GAAP) operating earnings per share, with a target of $4.05 for 100% payout.

E

John W. Rowe

Ex-CEO of Exelon

Education

Bachelor's degree from Harvard College; MBA from Harvard Business School.

Field of Expertise

Business & Management

Sector of Economy

Utilities

Born

January 1, 1945 - 80 years ago

CEO of Exelon for

10 years 11 months (Oct 2000 - Sep 2011)

Previous Experience

Chairman and Chief Executive Officer of Exelon Corporation since 2000.

Holdings

Track John W. Rowe's stock holdings and portfolio value over time.

Insider Trading

John W. Rowe's recent stock transactions, purchases, and sales filed with the SEC.

HCA

1,410 shares

HCA

May 1, 2019

Received

NTRS

$2.19K

NTRS at $95.94/share

Apr 23, 2019

Received

HCA

1,790 shares

HCA

May 2, 2018

Received

NTRS

1,033 shares

NTRS

Apr 17, 2018

Received

HCA

2,112 shares

HCA

May 3, 2017

Received

NTRS

1,214 shares

NTRS

Apr 25, 2017

Received

HCA

2,192 shares

HCA

May 4, 2016

Received

NTRS

1,531 shares

NTRS

Apr 19, 2016

Received

HCA

2,348 shares

HCA

May 6, 2015

Received

NTRS

1,530 shares

NTRS

Dec 31, 2014

Received

Rivals

Compare John W. Rowe with competitor CEOs and industry peers.